Peer Reviewed
Drug update

Lercanidipine and enalapril combination therapy for the treatment of hypertension

Karen A Duggan
Abstract
Lercanidipine plus enalapril (Zan-Extra) has been approved for use in patients with hypertension who have not reached blood pressure targets after treatment with either lercanidipine or enalapril monotherapy.
Key Points
    What is lercanidipine plus enalapril combination therapy?

    Lercanidipine plus enalapril (Zan-Extra) is a fixed dose combination antihypertensive medication, which consists of the dihydropyridine calcium channel blocker lercanidipine (Zanidip) and the angiotensin converting enzyme (ACE) inhibitor enalapril. There are two doses available: lercanidipine 10 mg plus enalapril 10 mg (Zan-Extra 10/10) and lercanidipine 10 mg plus enalapril 20 mg (Zan-Extra 10/20).

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?